BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38593176)

  • 21. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
    Chang XS; Zhu J; Yang T; Gao Y
    Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guanylate binding protein 5 triggers NF-κB activation to foster radioresistance, metastatic progression and PD-L1 expression in oral squamous cell carcinoma.
    Chiu HW; Lin CH; Lee HH; Lu HW; Lin YK; Lin YF; Lee HL
    Clin Immunol; 2024 Feb; 259():109892. PubMed ID: 38185269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic Vascular Density, the Expression of Podoplanin and Tumor Budding in Oral Squamous Cell Carcinoma.
    de Assis EM; Rodrigues M; Vieira JC; Pascoaloti MIM; Junior HM; Souto GR; Souza PEA; Horta MCR
    Head Neck Pathol; 2023 Jun; 17(2):371-382. PubMed ID: 36480090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-450b promotes cell migration and invasion by inhibiting SERPINB2 in oral squamous cell carcinoma.
    Wang X; Nie X; Xu G; Gao J; Wang B; Yang J; Song G
    Oral Dis; 2024 Mar; 30(2):376-389. PubMed ID: 36251494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
    Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
    Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipopolysaccharide enhances OSCC migration by promoting epithelial-mesenchymal transition.
    He Z; Deng R; Huang X; Ni Y; Yang X; Wang Z; Hu Q
    J Oral Pathol Med; 2015 Oct; 44(9):685-92. PubMed ID: 25367215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of p53 is associated with microbial acetaldehyde production in oralsquamous cell carcinoma.
    Marttila E; Rusanen P; Uittamo J; Salaspuro M; Rautemaa-Richardson R; Salo T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 May; 131(5):527-533. PubMed ID: 33858805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nickel ion inhibits nuclear factor-kappa B activity in human oral squamous cell carcinoma.
    Shionome T; Endo S; Omagari D; Asano M; Toyoma H; Ishigami T; Komiyama K
    PLoS One; 2013; 8(7):e68257. PubMed ID: 23844176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
    Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
    Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with
    Hsieh YP; Wu YH; Cheng SM; Lin FK; Hwang DY; Jiang SS; Chen KC; Chen MY; Chiang WF; Liu KJ; Huynh NC; Huang WT; Huang TT
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change and pathological significance of glycogen content in oral squamous cell carcinoma and oral submucous fibrosis.
    Nie H; Hu X; Xiong H; Zeng L; Chen W; Su T
    Tissue Cell; 2024 Apr; 87():102337. PubMed ID: 38430849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein overexpression of CIRP and TLR4 in oral squamous cell carcinoma: an immunohistochemical and clinical correlation analysis.
    Ren WH; Zhang LM; Liu HQ; Gao L; Chen C; Qiang C; Wang XL; Liu CY; Li SM; Huang C; Qi H; Zhi KQ
    Med Oncol; 2014 Aug; 31(8):120. PubMed ID: 25027624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and predictive values of SPP1, PAI and caveolin-1 in patients with oral squamous cell carcinoma.
    Huang CF; Yu GT; Wang WM; Liu B; Sun ZJ
    Int J Clin Exp Pathol; 2014; 7(9):6032-9. PubMed ID: 25337248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells.
    Min R; Siyi L; Wenjun Y; Shengwen L; Ow A; Lizheng W; Chenping Z
    Cancer Sci; 2012 Nov; 103(11):1938-45. PubMed ID: 22853846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma.
    Johnson J; Shi Z; Liu Y; Stack MS
    Oral Oncol; 2014 May; 50(5):468-77. PubMed ID: 24582884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
    Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
    J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.